New Hyde Park, N.Y.-based Northwell Health has appointed Geraldine O’Sullivan Coyne, MD, PhD, to system head and principal investigator for the system’s newly established Start Center for Cancer Research.
The unit — set to be the first Start center in New York state — will bring early stage clinical trials to the system’s R.J. Zuckerberg Cancer Center in New Hyde Park, according to a July 22 news release from Northwell.
Dr. O’Sullivan Coyne previously served as a clinical investigator at Start Dublin in Ireland and in various leadership roles during her seven years at the National Cancer Institute.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.